Replies to post #100540 on Biotech Values

[DewDiligence]

(AGN/MRX/JNJ)—Merz Pharma launches Xeomin in US:

http://finance.yahoo.com/news/Xeomin-incobotulinumtoxinA-a-prnews-3711195938.html?x=0&.v=1

Xeomin is a purer product than Botox and Dyport; it is very similar to JNJ’s PurTox botulinum toxin, which is nearing the BLA-submission stage.